Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.220
-0.010 (-0.81%)
Mar 18, 2025, 2:27 PM HKT

Dawnrays Pharmaceutical (Holdings) Company Description

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.

It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics.

It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules.

Dawnrays Pharmaceutical (Holdings) Limited was founded in 1995 and is headquartered in Wan Chai, Hong Kong.

Dawnrays Pharmaceutical (Holdings) Limited
Country Cayman Islands
Founded 1995
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,143
CEO Liwei Yu

Contact Details

Address:
CNT Tower
Wan Chai
Hong Kong
Phone 852 2111 9708
Website dawnrays.com

Stock Details

Ticker Symbol 2348
Exchange Hong Kong Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number KYG2687M1006
SIC Code 2833

Key Executives

Name Position
Liwei Yu Chief Executive Officer
Kei Ling Li Co-Founder and Executive Chairman
Yung Lai Hung Co-Founder and Executive Director
Yi Jun Wu Chief Financial Officer
Kit Ling Pang CPA Company Secretary